Search results for : p6 - Cancerrxgene - Genomics of Drug Sensitivity in Cancer

Name	Synonyms	Targets	Target Pathway	PubCHEM	Datatset	Sample size	Screening site
CGP-60474	KIN001-019, CGP60474, CGP 60474	CDK1,CDK2,CDK5,CDK7,CDK9, PKC	Cell cycle	644215	GDSC1	397	MGH
PARP_0108	SN1044053371	PARP1, PARP2, PARP6	Genome integrity		GDSC1	918	SANGER

Name	Cell Model Passport Link	COSMIC ID	Tissue	Tissue sub-type
CP66-MEL	SIDM00190	753546	SKCM	Skin
CP66-MEL	SIDM00190	753546	SKCM	Skin
CP67-MEL	SIDM00189	949092	SKCM	Skin

Feature Name	Feature Type
LRP6_mut	coding variant
USP6_mut	coding variant

The Genomics of Drug Sensitivity in Cancer Project is a collaboration between the Cancer Genome Project at the Wellcome Sanger Institute (UK) and the Center for Molecular Therapeutics, Massachusetts General Hospital Cancer Center (USA). This work is funded by Wellcome.

Users have a non-exclusive, non-transferable right to use data files for internal proprietary research and educational purposes, including target, biomarker and drug discovery. Excluded from this licence are use of the data (in whole or any significant part) for resale either alone or in combination with additional data/product offerings, or for provision of commercial services.
Please note: The data files are experimental and academic in nature and are not licensed or certified by any regulatory body. Genome Research Limited provides access to data files on an “as is” basis and excludes all warranties of any kind (express or implied).

Genomics of Drug Sensitivity in Cancer

Search Results for: p6